Publications by authors named "A K Saraf"

Background: Management of Diabetic Macular edema (DME) requires repeated injections. Therefore newer Anti-VEGFs like Brolucizumab with longer durability have been introduced. We compared two different dosages of Brolucizumab, 6.

View Article and Find Full Text PDF
Article Synopsis
  • Daytime sleepiness affects around 50% of patients with Parkinson's disease (PD), linked to poor quality of life and increased accident risks, but how medications and other factors play into this is not well understood.
  • Data from a study involving 453 PD patients revealed that orthostatic hypotension (OH) was not directly linked to excessive daytime sleepiness (EDS), but it was associated with depression among cognitively impaired patients.
  • Depression influenced EDS levels more in cognitively impaired patients compared to those who were cognitively normal, suggesting a need for further research on this complex relationship.
View Article and Find Full Text PDF

The Child Opportunity Index (COI) is a validated measurement that uses a composite index of 29 indicators of social determinants of health linked to the US Census. Patients post-Fontan palliation for single ventricle physiology often have reduced exercise capacity compared to the general population. Our hypothesis is that COI levels are directly associated with exercise capacity and inversely with late outcomes.

View Article and Find Full Text PDF

Cancer has emerged as a global health crisis, claiming millions of lives annually. Dendrimers and dendronized nanoparticles, a novel class of nanoscale molecules with highly branched three-dimensional macromolecular structures, have gained significant attention in cancer treatment and diagnosis due to their unique properties. These dendritic macromolecules offer a precisely controlled branching architecture, enabling functionalization with specific targeting molecules to enhance the selective delivery of therapeutic agents to tumor cells while minimizing systemic toxicity.

View Article and Find Full Text PDF

Prostate cancer survivors represent a growing population of patients with a diagnosis of prostate cancer, whether they were cured using local therapies or continue to receive systemic treatment of advanced disease. Many patients receive androgen deprivation therapy (ADT) during treatment, which is associated with many long-lasting physical and psychological effects. Identifying and addressing the needs of survivors is imperative for improving their health and well-being.

View Article and Find Full Text PDF